Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study
Ashley S. Felix(Wake Forest University), Louise A. Brinton(National Cancer Institute), Michael L. Pearl(Stony Brook University), Premal H. Thaker(Washington University in St. Louis), Wei Deng(Wuhan University), David S. Miller(Southwestern Medical Center), C Nagel(Case Western Reserve University), John F. Boggess(University of Kentucky), Richard G. Moore(University of Rochester Medical Center), Joan L. Walker(Cornell University), Saketh R. Guntupalli(University of Colorado Cancer Center), Shashikant Lele(Memorial Sloan Kettering Cancer Center), David G. Mutch(Cancer Research Center), David E. Cohn(The Ohio State University), Levi S. Downs(University of Toronto), Theodore M. Brasky(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), William T. Creasman(Medical University of South Carolina), Olga B. Ioffe(University of Maryland, Baltimore)
Cited by 34
Related Papers
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology
|Archives of Pathology & Laboratory Medicine|2012|999
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
|The Lancet Oncology|2017|929
<scp>FIGO</scp> staging of endometrial cancer: 2023
|International Journal of Gynecology & Obstetrics|2023|926